Quantum computing will help in rationalizing clinical trials and respective Pharmacogenetics -processes
Abstract
Quantum computing at present is in keen focus across the globe in respect to the huge advantages it holds for the current and future generations. With the help of supercomputing powers we can achieve the unachievable in fraction of hours if not days or years. Quantum computing will help in advances in clinical research and medicine via rationalizing the practical outcomes from any given said trials or pharmacogenetical process. It will help in focusing on the better outcomes rather than secondary outcomes which may not be fruitful for us or future generations. Hence, the present letter has been written in order to bring in the notice the invention of quantum computing holds for the research industry.
Read the paper
Related studies
- In silico toxicology protocols
- QM7-X, a comprehensive dataset of quantum-mechanical properties spanning the chemical space of small organic molecules
- Quantum Informed Machine-Learning Potentials for Molecular Dynamics Simulations of CO2's Chemisorption and Diffusion in Mg-MOF-74
- In-silico strategies in nano-drug design: Bridging nanomaterials and pharmacological applications
- mRNA codon optimization with quantum computers
- The computational power of the human brain
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.